CCCC C4 Therapeutics Inc

$CCCC heavily shorted stock, Jp upgrade big deal, expect a squeeze at closing bell or ah

$CCCC is toying with its 50 week MA right now. 42.53% short interest. 52.73% off exchange short volume. Earnings expected Nov. 5th, in pre-market.

$CCCC Despite today's pullback, C4 Therapeutics reported a healthy cash balance of ~$300M in its recent Q2 update, providing a operational runway projected through late 2028 as its Phase 2 MOMENTUM trial continues.

$CCCC lol. This is why i dont follow these fake gurus drawing lines and saying it should be $20 per share based on lines

$CCCC The relentless increase in short interest is the one thing that gives me pause. The data remain strong and the balance sheet is solid, so this looks increasingly like a bet on the long catalyst gap and continued dilution rather than a broken clinical thesis. Next short-interest print will be telling…

$CCCC Well, the poster mentioned he was adding CCCC and I asked why now? The generalizations I mentioned apply to CCCC, and other biotechs...and the entire stock market, with a few exceptions. The tide has clearly turned on biotechs starting several months ago, so why buy CCCC or any other biotech now in the absence of significant positive news. And other overriding negative forces on the market = downward pressure. CCCC is still up 100% in 18 months = room to retrace. The seemingly selling of warrants when the stock is low tells me management not expecting this thing to go to 10 anytime soon. Roche coughing up $600 million to NRIX earlier this year and only a couple million to CCCC Fact check me - I think there are ~800 ongoing clinical trials for various leukemias – what sets CCCC apart? Drug combos after previous failed how many prior lines of treatment? + side Partnerships are somewhat impressive, and who knows what the PFE collab / clinical data might bring.

$CCCC disclosed new biomarker data from its Phase 1 cemsidomide trial in multiple myeloma.

$CCCC Unless one sold out of money calls or buying puts and endured the huge spreads on the options.

$CCCC Why take a chance? THe mess in this world is only going to get worse - nobody is going to want to take a chance on money burning biotechs when this 10 yr phone 'transisitory' inflation is about to go into an even higher gear and their water, food and tax bill is up another 30% and shipping costing more than the underlying parcel in lots of cases, esp LTL freight. IMO, most of these biotechs, many that are still up 100-2000% in 17 months are going to get cut in half again before end of year - and those long term capital gain holders will still be making money. Like I posted over a year ago - simple observation of the dwindling bug population and water tells me all I need to know about the direction of our fate. Good luck

$CCCC Ouch, still going to be a bag holder as I believe cemisomide still looks very promising for best in class. plan to hold my 20k shares and building for the next 4 years. shorts can manipulate in the meantime, phase II readout will be huge game changer here.